,

–

Weisgraber, K.H., Rall, S.C. Jr., Mehley, R.W.,

Human E apoprotein heterogeneity: cysteine- arginine interchanges in the amino acid sequence of the ap

isoforms. J. Biol. Chem.

,

–

Bertomeu, A., Ros, E., Zambon, D., Vela, M., Perez, A.R.M., Targarona, E., Trias, M., et al., 1996. Apolipoprotein E polymorphism and gallstones. Gastroenterology 111, 1603–1610. Breslow, J.L., Zannis, V.I., SanGiacomo, T.R., et al., 1982. Studies of familial type III hyperlipo- proteinemia using as a genetic marker the apoE phenotype E2:2. J. Lipid Res. 23, 1224–1235. Chang-En, Y., Junko, O., Ying-Hui, F., Ellen, M.W., Fuki, H., Reid, A., Schellenberg, G.D., et al., 1996. Positional cloning of the Werner’s Syndrome gene. Science 272, 258–262. Davignon, J., Gregg, R.E., Sing, C.F., 1988. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8, 1–21.

Wenham, P.R., Price, W.H., Blundell, G.,

Apolipoprotein E genotyping by one-stage PCR. Lancet

,

–

Yong-Xing, M., Yue, Z., Zan-Shun, W., et al.,

HLA and longevity among Shanghai Chinese. Mech. Ageing Develop.

,

–

Zannis, V.I., Breslow, J.L.,

Human VLDL ap

isoprotein polymorphism is explained by genetic variation and post-translational modification. Biochemistry

,

–